Ueno, Masayuki https://orcid.org/0000-0002-2497-9327
Takeda, Haruhiko
Takai, Atsushi https://orcid.org/0000-0002-5233-4120
Morimura, Hiroki
Nishijima, Norihiro
Iwamoto, Satoru
Okuyama, Shunsuke
Umeda, Makoto
Seta, Takeshi
Ikeda, Atsuyuki
Goto, Tomoyuki
Miyamoto, Shin’ichi
Kayahara, Takahisa
Uenoyama, Yoshito
Matsumura, Kazuyoshi
Nakano, Shigeharu
Mishima, Masako
Inuzuka, Tadashi
Eso, Yuji
Takahashi, Ken
Marusawa, Hiroyuki
Osaki, Yukio
Hatano, Etsuro
Seno, Hiroshi
Article History
Received: 5 June 2024
Accepted: 5 September 2024
First Online: 18 September 2024
Change Date: 18 October 2024
Change Type: Update
Change Details: This article was revised to correct the reference citation in the sentence beginning ‘Despite significant efforts to explore predictive...’.
Change Date: 21 October 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00535-024-02159-y
Declarations
:
: Etsuro Hatano has received honoraria from Chugai Pharmaceutical, Eisai, and AstraZeneca; Hiroshi Seno has received honoraria from Eisai.
: All procedures were performed in accordance with the Helsinki Declaration of 1964, as revised in 2013. The Kyoto University Graduate School and Faculty of Medicine Ethics Committee approved the study protocol (No. R3950). Informed consent was obtained from each patient using an opt-out method.